Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ
Closed
Sep 21, 2026
Day's Range
24.1452 wk Range
17.34Overview - KMTS - Kestra Medical Technologies, Ltd.
Key Statistics
Valuation
Enterprise Value
1.33B
P/E (Forward)
‪-11.88‬
PEG Ratio
‪-11.88‬
Price / Sales (TTM)
‪13.63‬
Price / Book
‪6.51‬
EV / EBITDA
‪-9.93‬
Profitability
Gross Margin
‪54.75%‬
Profit Margin
‪-140.42%‬
Operating Margin
‪-121.58%‬
Return on Assets
‪-29.23%‬
Return on Equity
‪-73.73%‬
Ownership
Shares Outstanding
58.38M
Float
33.69M
Short % of Shares Outstanding
‪9.54%‬
Held by Insiders
‪5.26%‬
Held by Institutions
‪101.64%‬
Price stats
50-Day Avg
‪25.09‬
200-Day Avg
‪23.50‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
8 analysts
Average price target
‪$ 30.00‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KMTS - Kestra Medical Technologies, Ltd.
Peers - KMTS - Kestra Medical Technologies, Ltd.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
- KMTSNASDAQKestra Medical Technologies, Ltd.1.47BMarket Cap-3.15%52-week change—P/E (Trailing)‪-140.42%‬Profit Margin
- ISRGNASDAQIntuitive Surgical Inc.140.92BMarket Cap-13.02%52-week change43.29P/E (Trailing)‪28.44%‬Profit Margin
- MDLNNASDAQMedline Inc. Class A Common Stock42.56BMarket Cap-29.58%52-week change40.05P/E (Trailing)‪2.31%‬Profit Margin
- ALGNNASDAQAlign Technology, Inc.10.71BMarket Cap+13.10%52-week change26.18P/E (Trailing)‪9.99%‬Profit Margin
- COONASDAQCooper Cos Inc-The10.51BMarket Cap-22.99%52-week change18.33P/E (Trailing)‪13.46%‬Profit Margin
- RGENNASDAQRepligen Corporation9.98BMarket Cap+28.80%52-week change242.32P/E (Trailing)‪5.29%‬Profit Margin
- MMSINASDAQMerit Medical Systems, Inc.5.09BMarket Cap+2.08%52-week change35.51P/E (Trailing)‪9.22%‬Profit Margin
Profile Summary - KMTS - Kestra Medical Technologies, Ltd.
About
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on cardiovascular care. Kestra Medical Technologies develops and commercializes the Cardiac Recovery System, an integrated platform designed to support patients at elevated risk of sudden cardiac…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
